Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Modern Rheumatology|November 19, 2024
Effectiveness and safety of low-energy shock wave therapy for digital ulcers associated with systemic sclerosis: A Phase 3 pivotal clinical trialTomonori Ishii, Yasushi Kawaguchi, Osamu Ishikawa, et al.
Plos One|January 11, 2021
The psychological effects of COVID-19 on hospital workers at the beginning of the outbreak with a large disease cluster on the Diamond Princess cruise shipKeiko Ide, Takeshi Asami, Akira Suda, et al.
Clinical and Experimental Rheumatology|September 8, 2020
Rheumatoid arthritis patients with low baseline Health Assessment Questionnaire scores have a risk of functional disability progression: a post hoc analysis of a nationwide longitudinal cohort in JapanRemi Sumiyoshi, Toshihiko Hidaka, Tomohiro Koga, et al.
Plos One|May 16, 2017
Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving remission or low disease activity: A post hoc analysis of a nationwide cohort in JapanTomohiro Koga, Akitomo Okada, Takaaki Fukuda, et al.
Medicine|April 29, 2016
Prognostic Factors Toward Clinically Relevant Radiographic Progression in Patients With Rheumatoid Arthritis in Clinical Practice: A Japanese Multicenter, Prospective Longitudinal Cohort Study for Achieving a Treat-to-Target StrategyTomohiro Koga, Akitomo Okada, Takaaki Fukuda, et al.
Modern Rheumatology|March 3, 2016
Clinical and structural remission rates increased annually and radiographic progression was continuously inhibited during a 3-year administration of tocilizumab in patients with rheumatoid arthritis: A multi-center, prospective cohort study by the Michinoku Tocilizumab Study GroupYasuhiko Hirabayashi, Yasuhiko Munakata, Masayuki Miyata, et al.
Fukushima Journal of Medical Science|March 29, 2023
Feasibility of methotrexate discontinuation following tocilizumab and methotrexate combination therapy in patients with long-standing and advanced rheumatoid arthritis: a 3-year observational cohort studyMasayuki Miyata, Yasuhiko Hirabayashi, Yasuhiko Munakata, et al.
Pageof 11